Loading
Total declarations
Companies
▲ Purchases (1 ops.)
▼ Sales (2 ops.)
Latest filing published 10 Feb 2026 for Zentalis Pharmaceuticals, Inc., €16k.
Filing timeline
BuySaleJulia Marie Eastland
Insider track record
Disclosed buys
1
Disclosed sells
2
Signal history
Closed purchases
Market purchases
1
Not enough history yet: 1 closed purchase, at least 2 are needed.
Purchases by company
Since each purchase
- +3.3%Entry US$2.14 · Close at T+365 US$2.21
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Julia Marie Eastland: trading record in brief
This profile gathers the share dealings of Julia Marie Eastland across 6 companies, led by Harpoon Therapeutics, Inc., Zentalis Pharmaceuticals, Inc. and Cascadian Therapeutics, Inc. Between 11 January 2018 and 9 February 2026, the trades on record add up to 16 filings.
On the open market, the record shows 1 purchase worth €47k and 2 sales worth €18k. Netting one side against the other leaves €29k of net buying. Unlike grants, an open-market purchase is paid for by the insider, at the market price. Besides market trades, the filings include 9 share grants and 1 option exercise. Since January 2026: no purchases and 2 sales on the market.
Most recently, on 10 February 2026, the filings show an open-market sale worth €1,797 in Zentalis Pharmaceuticals, Inc. The most recent open-market purchase was published on 4 February 2025, 627 days ago. Filings reach the SEC (Form 4) feed a median of 4 days after the trade. For comparison, the SEC allows two business days to file a Form 4. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Julia Marie Eastland
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations11 total
7,866 shares@ US$2.429725.5% of flowCommon StockSEC:0001500189-26-000004:0
2,537 shares0Common StockSEC:0001062993-25-009692:0
59,388 shares0Common StockSEC:0001725160-25-000036:0
28,500 shares@ US$1.731474.5% of flowCommon StockSEC:0001725160-25-000028:0
Canonical exit: 1 May 2025 (T+90)
1,345 shares0Common StockSEC:0001062993-24-016538:0
5,357 shares0Common StockSEC:0000950170-24-065588:0
31,250 shares0Common StockSEC:0000950170-24-029430:0
178,500 shares0Common StockSEC:0000950170-24-003365:0
50,000 shares0Common StockSEC:0001209191-23-056805:0
5,357 shares0Common StockSEC:0001209191-23-033162:0
1,429 sharesCommon StockSEC:0001209191-23-021301:0
11 of 11 declarations
